SpringerLink
Log in

Sleep and Attention-Deficit/Hyperactivity Disorder

  • Chapter
  • First Online:
Sleep and Neuropsychiatric Disorders

  • 1058 Accesses

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is often associated with comorbid sleep disturbances. Sleep disturbances may be a risk factor for development of the disorder, a symptom of a comorbid psychiatric/primary sleep disorder, or a side effect of medications used to treat ADHD. Current guidelines recommend assessing sleep problems prior to initiating pharmacotherapy, yet not all clinicians are aware of the extent to which ADHD and sleep have been associated. As such, this chapter (1) provides information regarding the nature of the associations between ADHD and primary sleep disorders, comorbid psychiatric disorders, and medications aforementioned; (2) describes overlap** pathophysiology; and (3) discusses implications for treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Thomas R, et al. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994–1001.

    Article  PubMed  Google Scholar 

  2. Polanczyk G, Rohde LA. Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Curr Opin Psychiatry. 2007;20(4):386–92.

    Article  PubMed  Google Scholar 

  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC; 2013.

    Google Scholar 

  4. Tsai MH, Hsu JF, Huang YS. Sleep problems in children with attention deficit/hyperactivity disorder: current status of knowledge and appropriate management. Curr Psychiatry Rep. 2016;18(8):76.

    Article  PubMed  Google Scholar 

  5. Owens JA. The ADHD and sleep conundrum: a review. J Dev Behav Pediatr. 2005;26(4):312–22.

    Article  PubMed  Google Scholar 

  6. Um YH, Hong SC, Jeong JH. Sleep problems as predictors in attention-deficit hyperactivity disorder: causal mechanisms, consequences and treatment. Clin Psychopharmacol Neurosci. 2017;15(1):9–18.

    Article  PubMed  PubMed Central  Google Scholar 

  7. American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darrien, IL: American Academy of Sleep Medicine; 2014.

    Google Scholar 

  8. Pavlova M, Latreille V. Sleep disorders. Am J Med. 2019;132(3):292–9.

    Article  Google Scholar 

  9. Allen RP, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165(11):1286–92.

    Article  PubMed  Google Scholar 

  10. Picchietti D, et al. Restless legs syndrome: prevalence and impact in children and adolescents—the Peds REST study. Pediatrics. 2007;120(2):253–66.

    Article  PubMed  Google Scholar 

  11. Picchietti DL, et al. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol. 1998;13(12):588–94.

    Article  PubMed  CAS  Google Scholar 

  12. Pullen SJ, et al. Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study. J Clin Sleep Med. 2011;7(6):587–96.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sadeh A, Pergamin L, Bar-Haim Y. Sleep in children with attention-deficit hyperactivity disorder: a meta-analysis of polysomnographic studies. Sleep Med Rev. 2006;10(6):381–98.

    Article  PubMed  Google Scholar 

  14. Cortese S, et al. Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep. 2005;28(8):1007–13.

    Article  PubMed  Google Scholar 

  15. Konofal E, et al. Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children. Sleep Med. 2007;8(7–8):711–5.

    Article  PubMed  Google Scholar 

  16. Angriman M, Cortese S, Bruni O. Somatic and neuropsychiatric comorbidities in pediatric restless legs syndrome: a systematic review of the literature. Sleep Med Rev. 2017;34:34–45.

    Article  PubMed  Google Scholar 

  17. Durmer JS, Quraishi GH. Restless legs syndrome, periodic leg movements, and periodic limb movement disorder in children. Pediatr Clin N Am. 2011;58(3):591–620.

    Article  Google Scholar 

  18. Roy M, et al. Association between restless legs syndrome and adult ADHD in a German community-based sample. J Atten Disord. 2018;22(3):300–8.

    Article  PubMed  Google Scholar 

  19. Stein MA. Medical mimics and differential diagnosis in adult ADHD. CNS Spectr. 2008;13(10 Suppl 15):14–6.

    Article  PubMed  Google Scholar 

  20. Wagner ML, Walters AS, Fisher BC. Symptoms of attention-deficit/hyperactivity disorder in adults with restless legs syndrome. Sleep. 2004;27(8):1499–504.

    Article  PubMed  Google Scholar 

  21. Haschka D, et al. Association of mitochondrial iron deficiency and dysfunction with idiopathic restless legs syndrome. Mov Disord. 2019;34(1):114–23.

    Article  PubMed  CAS  Google Scholar 

  22. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol. 2005;4(8):465–75.

    Article  PubMed  CAS  Google Scholar 

  23. Mitchell UH, et al. Peripheral dopamine in restless legs syndrome. Front Neurol. 2018;9:155.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Cervenka S, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain. 2006;129(Pt 8):2017–28.

    Article  PubMed  Google Scholar 

  25. Hening W, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5(3):237–46.

    Article  PubMed  Google Scholar 

  26. Bogan RK, et al. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc. 2006;81(1):17–27.

    Article  PubMed  CAS  Google Scholar 

  27. Rizzo G, et al. Brain imaging and networks in restless legs syndrome. Sleep Med. 2017;31:39–48.

    Article  PubMed  Google Scholar 

  28. Yeh P, Walters AS, Tsuang JW. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath. 2012;16(4):987–1007.

    Article  PubMed  Google Scholar 

  29. Li X, et al. Brain iron deficiency in idiopathic restless legs syndrome measured by quantitative magnetic susceptibility at 7 tesla. Sleep Med. 2016;22:75–82.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Picchietti MA, Picchietti DL. Advances in pediatric restless legs syndrome: iron, genetics, diagnosis and treatment. Sleep Med. 2010;11(7):643–51.

    Article  PubMed  Google Scholar 

  31. Ekbom K, Ulfberg J. Restless legs syndrome. J Intern Med. 2009;266(5):419–31.

    Article  PubMed  CAS  Google Scholar 

  32. Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord. 2007;22(Suppl 18):S440–8.

    Article  PubMed  Google Scholar 

  33. Allen RP, et al. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Sleep Med. 2018;41:27–44.

    Article  PubMed  Google Scholar 

  34. Trotti LM, Bhadriraju S, Becker LA. Iron for restless legs syndrome. Cochrane Database Syst Rev. 2012;5(5):Cd007834.

    Google Scholar 

  35. Mehmood T, et al. Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease). Sleep Med. 2014;15(12):1473–6.

    Article  PubMed  Google Scholar 

  36. Philipsen A, Hornyak M, Riemann D. Sleep and sleep disorders in adults with attention deficit/hyperactivity disorder. Sleep Med Rev. 2006;10(6):399–405.

    Article  PubMed  Google Scholar 

  37. Konofal E, et al. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2004;158(12):1113–5.

    Article  PubMed  Google Scholar 

  38. Wang Y, et al. Iron status in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169145.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Bener A, et al. Higher prevalence of iron deficiency as strong predictor of attention deficit hyperactivity disorder in children. Ann Med Health Sci Res. 2014;4(Suppl 3):S291–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Gordon SL, et al. Tyrosine hydroxylase activity is regulated by two distinct dopamine-binding sites. J Neurochem. 2008;106(4):1614–23.

    PubMed  CAS  Google Scholar 

  41. Daubner SC, Le T, Wang S. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys. 2011;508(1):1–12.

    Article  PubMed  CAS  Google Scholar 

  42. Lahat E, et al. Iron deficiency in children with attention deficit hyperactivity disorder. Isr Med Assoc J. 2011;13(9):530–3.

    PubMed  Google Scholar 

  43. Earley CJ, Heckler D, Allen RP. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome. Sleep Med. 2005;6(4):301–5.

    Article  PubMed  Google Scholar 

  44. Konofal E, et al. Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol. 2008;38(1):20–6.

    Article  PubMed  Google Scholar 

  45. Hogl B, Comella C. Therapeutic advances in restless legs syndrome (RLS). Mov Disord. 2015;30(11):1574–9.

    Article  PubMed  Google Scholar 

  46. Wilt TJ, et al. Pharmacologic therapy for primary restless legs syndrome: a systematic review and meta-analysis. JAMA Intern Med. 2013;173(7):496–505.

    Article  PubMed  CAS  Google Scholar 

  47. Cortese S, et al. Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2013;52(8):784–96.

    Article  PubMed  Google Scholar 

  48. Young T, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–5.

    Article  PubMed  CAS  Google Scholar 

  49. Bonuck KA, et al. Prevalence and persistence of sleep disordered breathing symptoms in young children: a 6-year population-based cohort study. Sleep. 2011;34(7):875–84.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Lumeng JC, Chervin RD. Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc. 2008;5(2):242–52.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Senaratna CV, et al. Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev. 2017;34:70–81.

    Article  PubMed  Google Scholar 

  52. Cortese S, et al. Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry. 2009;48(9):894–908.

    PubMed  Google Scholar 

  53. Sedky K, Bennett DS, Carvalho KS. Attention deficit hyperactivity disorder and sleep disordered breathing in pediatric populations: a meta-analysis. Sleep Med Rev. 2014;18(4):349–56.

    Article  PubMed  Google Scholar 

  54. Rosen CL, et al. Prevalence and risk factors for sleep-disordered breathing in 8- to 11-year-old children: association with race and prematurity. J Pediatr. 2003;142(4):383–9.

    Article  PubMed  Google Scholar 

  55. Bixler EO, et al. Sleep disordered breathing in children in a general population sample: prevalence and risk factors. Sleep. 2009;32(6):731–6.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Oguzturk O, et al. Attention deficit/hyperactivity disorder in adults with sleep apnea. J Clin Psychol Med Settings. 2013;20(2):234–9.

    Article  PubMed  Google Scholar 

  57. Blesch L, Breese McCoy SJ. Obstructive sleep apnea mimics attention deficit disorder. J Atten Disord. 2016;20(1):41–2.

    Article  PubMed  Google Scholar 

  58. Moturi S, Avis K. Assessment and treatment of common pediatric sleep disorders. Psychiatry (Edgmont). 2010;7(6):24–37.

    Google Scholar 

  59. Blunden S, et al. Behavior and neurocognitive performance in children aged 5-10 years who snore compared to controls. J Clin Exp Neuropsychol. 2000;22(5):554–68.

    Article  PubMed  CAS  Google Scholar 

  60. Henriques PSF. Sleep disorder investigation might be considered to be mandatory in attention deficit/hyperactivity disorder guideline. Arq Neuropsiquiatr. 2016;74(9):701–7.

    Article  Google Scholar 

  61. Schechter MS. Technical report: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2002;109(4):e69.

    Article  PubMed  Google Scholar 

  62. Huang YS, et al. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study. Sleep Med. 2007;8(1):18–30.

    Article  PubMed  CAS  Google Scholar 

  63. Surman CB, et al. Adults with ADHD and sleep complaints: a pilot study identifying sleep-disordered breathing using polysomnography and sleep quality assessment. J Atten Disord. 2006;9(3):550–5.

    Article  PubMed  Google Scholar 

  64. O’Brien LM, et al. Sleep and neurobehavioral characteristics of 5- to 7-year-old children with parentally reported symptoms of attention-deficit/hyperactivity disorder. Pediatrics. 2003;111(3):554–63.

    Article  PubMed  Google Scholar 

  65. Rhodes SK, et al. Neurocognitive deficits in morbidly obese children with obstructive sleep apnea. J Pediatr. 1995;127(5):741–4.

    Article  PubMed  CAS  Google Scholar 

  66. Tsubomatsu C, et al. Diagnosis and treatment of obstructive sleep apnea syndrome in children. Adv Otorhinolaryngol. 2016;77:105–11.

    PubMed  Google Scholar 

  67. Owens J, et al. Sleep and daytime behavior in children with obstructive sleep apnea and behavioral sleep disorders. Pediatrics. 1998;102(5):1178–84.

    Article  PubMed  CAS  Google Scholar 

  68. Smith DL, et al. Parent-reported behavioral and psychiatric problems mediate the relationship between sleep-disordered breathing and cognitive deficits in school-aged children. Front Neurol. 2017;8:410.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Lal C, Strange C, Bachman D. Neurocognitive impairment in obstructive sleep apnea. Chest. 2012;141(6):1601–10.

    Article  PubMed  Google Scholar 

  70. Spruyt K, Gozal D. Sleep disturbances in children with attention-deficit/hyperactivity disorder. Expert Rev Neurother. 2011;11(4):565–77.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Row BW, et al. Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. Am J Respir Crit Care Med. 2003;167(11):1548–53.

    Article  PubMed  Google Scholar 

  72. Xu W, et al. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience. 2004;126(2):313–23.

    Article  PubMed  CAS  Google Scholar 

  73. Davies CR, Harrington JJ. Impact of obstructive sleep apnea on neurocognitive function and impact of continuous positive air pressure. Sleep Med Clin. 2016;11(3):287–98.

    Article  PubMed  Google Scholar 

  74. McCoy JG, et al. One week of exposure to intermittent hypoxia impairs attentional set-shifting in rats. Behav Brain Res. 2010;210(1):123–6.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Beebe DW, Gozal D. Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. J Sleep Res. 2002;11(1):1–16.

    Article  PubMed  Google Scholar 

  76. Adams N, et al. Relation of measures of sleep-disordered breathing to neuropsychological functioning. Am J Respir Crit Care Med. 2001;163(7):1626–31.

    Article  PubMed  CAS  Google Scholar 

  77. Beebe DW, et al. The neuropsychological effects of obstructive sleep apnea: a meta-analysis of norm-referenced and case-controlled data. Sleep. 2003;26(3):298–307.

    Article  PubMed  Google Scholar 

  78. Aloia MS, et al. Neuropsychological sequelae of obstructive sleep apnea-hypopnea syndrome: a critical review. J Int Neuropsychol Soc. 2004;10(5):772–85.

    Article  PubMed  Google Scholar 

  79. Jackson ML, Howard ME, Barnes M. Cognition and daytime functioning in sleep-related breathing disorders. Prog Brain Res. 2011;190:53–68.

    Article  PubMed  Google Scholar 

  80. Row BW, et al. Impaired spatial learning and hyperactivity in develo** rats exposed to intermittent hypoxia. Pediatr Res. 2002;52(3):449–53.

    Article  PubMed  Google Scholar 

  81. Bass JL, et al. The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence. Pediatrics. 2004;114(3):805–16.

    Article  PubMed  Google Scholar 

  82. Miano S, et al. Sleep-related disorders in children with attention-deficit hyperactivity disorder: preliminary results of a full sleep assessment study. CNS Neurosci Ther. 2016;22(11):906–14.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  83. Carmona S, et al. Global and regional gray matter reductions in ADHD: a voxel-based morphometric study. Neurosci Lett. 2005;389(2):88–93.

    Article  PubMed  CAS  Google Scholar 

  84. Al-Amin M, Zinchenko A, Geyer T. Hippocampal subfield volume changes in subtypes of attention deficit hyperactivity disorder. Brain Res. 2018;1685:1–8.

    Article  PubMed  CAS  Google Scholar 

  85. Cortese S, et al. Attention-deficit/hyperactivity disorder (ADHD) and obesity: a systematic review of the literature. Crit Rev Food Sci Nutr. 2008;48(6):524–37.

    Article  PubMed  Google Scholar 

  86. Schwartz AR, et al. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc. 2008;5(2):185–92.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Goraya JS, et al. Sleep study abnormalities in children with attention deficit hyperactivity disorder. Pediatr Neurol. 2009;40(1):42–6.

    Article  PubMed  Google Scholar 

  88. Romero-Corral A, et al. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest. 2010;137(3):711–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  89. Frye SS, et al. Childhood obesity, weight loss and developmental trajectories predict the persistence and remission of childhood sleep-disordered breathing. Pediatr Obes. 2018;14(1).

    Google Scholar 

  90. Roche J, et al. Obstructive sleep apnea and sleep architecture in adolescents with severe obesity: effects of a 9-month lifestyle modification program based on regular exercise and a balanced diet. J Clin Sleep Med. 2018;14(6):967–76.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Ivanhoe JR, Lefebvre CA, Stockstill JW. Sleep disordered breathing in infants and children: a review of the literature. Pediatr Dent. 2007;29(3):193–200.

    PubMed  Google Scholar 

  92. Verhulst SL, et al. The effect of weight loss on sleep-disordered breathing in obese teenagers. Obesity (Silver Spring). 2009;17(6):1178–83.

    Article  Google Scholar 

  93. Strobel RJ, Rosen RC. Obesity and weight loss in obstructive sleep apnea: a critical review. Sleep. 1996;19(2):104–15.

    Article  PubMed  CAS  Google Scholar 

  94. Naseem S, Chaudhary B, Collop N. Attention deficit hyperactivity disorder in adults and obstructive sleep apnea. Chest. 2001;119(1):294–6.

    Article  PubMed  CAS  Google Scholar 

  95. Marcus CL, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130(3):e714–55.

    Article  PubMed  Google Scholar 

  96. Marcus CL, et al. Effects of positive airway pressure therapy on neurobehavioral outcomes in children with obstructive sleep apnea. Am J Respir Crit Care Med. 2012;185(9):998–1003.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Amin R, et al. Growth velocity predicts recurrence of sleep-disordered breathing 1 year after adenotonsillectomy. Am J Respir Crit Care Med. 2008;177(6):654–9.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Amiri S, et al. Effect of adenotonsillectomy on ADHD symptoms of children with adenotonsillar hypertrophy and sleep disordered breathing. Int J Pediatr Otorhinolaryngol. 2015;79(8):1213–7.

    Article  PubMed  Google Scholar 

  99. Redline S, et al. The Childhood Adenotonsillectomy Trial (CHAT): rationale, design, and challenges of a randomized controlled trial evaluating a standard surgical procedure in a pediatric population. Sleep. 2011;34(11):1509–17.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Marcus CL, et al. A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013;368(25):2366–76.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  101. Mitchell RB, et al. The use of clinical parameters to predict obstructive sleep apnea syndrome severity in children: the Childhood Adenotonsillectomy (CHAT) study randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2015;141(2):130–6.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Sadeh A, Gruber R, Raviv A. The effects of sleep restriction and extension on school-age children: what a difference an hour makes. Child Dev. 2003;74(2):444–55.

    Article  PubMed  Google Scholar 

  103. Schrader H, Bovim G, Sand T. The prevalence of delayed and advanced sleep phase syndromes. J Sleep Res. 1993;2(1):51–5.

    Article  PubMed  CAS  Google Scholar 

  104. Lovato N, et al. Delayed sleep phase disorder in an Australian school-based sample of adolescents. J Clin Sleep Med. 2013;9(9):939–44.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Sivertsen B, et al. Delayed sleep phase syndrome in adolescents: prevalence and correlates in a large population based study. BMC Public Health. 2013;13:1163.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Bijlenga D, et al. Associations between sleep characteristics, seasonal depressive symptoms, lifestyle, and ADHD symptoms in adults. J Atten Disord. 2013;17(3):261–75.

    Article  PubMed  Google Scholar 

  107. Hysing M, et al. Association between sleep problems and symptoms of attention deficit hyperactivity disorder in adolescence: results from a large population-based study. Behav Sleep Med. 2016;14(5):550–64.

    Article  PubMed  Google Scholar 

  108. Gamble KL, et al. Delayed sleep timing and symptoms in adults with attention-deficit/hyperactivity disorder: a controlled actigraphy study. Chronobiol Int. 2013;30(4):598–606.

    Article  PubMed  Google Scholar 

  109. Pandi-Perumal SR, et al. Dim light melatonin onset (DLMO): a tool for the analysis of circadian phase in human sleep and chronobiological disorders. Prog Neuro-Psychopharmacol Biol Psychiatry. 2007;31(1):1–11.

    Article  CAS  Google Scholar 

  110. Bron TI, et al. Attention-deficit hyperactivity disorder symptoms add risk to circadian rhythm sleep problems in depression and anxiety. J Affect Disord. 2016;200:74–81.

    Article  PubMed  CAS  Google Scholar 

  111. Kooij JJ, Bijlenga D. The circadian rhythm in adult attention-deficit/hyperactivity disorder: current state of affairs. Expert Rev Neurother. 2013;13(10):1107–16.

    Article  PubMed  CAS  Google Scholar 

  112. Sivertsen B, et al. Mental health problems in adolescents with delayed sleep phase: results from a large population-based study in Norway. J Sleep Res. 2015;24(1):11–8.

    Article  PubMed  Google Scholar 

  113. Coogan AN, McGowan NM. A systematic review of circadian function, chronotype and chronotherapy in attention deficit hyperactivity disorder. Atten Defic Hyperact Disord. 2017;9(3):129–47.

    Article  PubMed  Google Scholar 

  114. Durmus FB, Arman AR, Ayaz AB. Chronotype and its relationship with sleep disorders in children with attention deficit hyperactivity disorder. Chronobiol Int. 2017;34(7):886–94.

    Article  PubMed  Google Scholar 

  115. Van Veen MM, et al. Delayed circadian rhythm in adults with attention-deficit/hyperactivity disorder and chronic sleep-onset insomnia. Biol Psychiatry. 2010;67(11):1091–6.

    Article  PubMed  Google Scholar 

  116. Van der Heijden KB, et al. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry. 2007;46(2):233–41.

    Article  PubMed  Google Scholar 

  117. McGowan NM, Coogan AN. Sleep and circadian rhythm function and trait impulsivity: an actigraphy study. Psychiatry Res. 2018;268:251–6.

    Article  PubMed  Google Scholar 

  118. Wyatt JK. Circadian rhythm sleep disorders. Pediatr Clin N Am. 2011;58(3):621–35.

    Article  Google Scholar 

  119. Zhu L, Zee PC. Circadian rhythm sleep disorders. Neurol Clin. 2012;30(4):1167–91.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Nesbitt AD. Delayed sleep-wake phase disorder. J Thorac Dis. 2018;10(Suppl 1):S103–s111.

    Article  PubMed  PubMed Central  Google Scholar 

  121. Micic G, et al. Nocturnal melatonin profiles in patients with delayed sleep-wake phase disorder and control sleepers. J Biol Rhythm. 2015;30(5):437–48.

    Article  CAS  Google Scholar 

  122. Carpenter JS, et al. Pineal volume and evening melatonin in young people with affective disorders. Brain Imaging Behav. 2017;11(6):1741–50.

    Article  PubMed  Google Scholar 

  123. Sigurdardottir LG, et al. Pineal gland volume assessed by MRI and its correlation with 6-sulfatoxymelatonin levels among older men. J Biol Rhythm. 2016;31(5):461–9.

    Article  Google Scholar 

  124. Crowley SJ, Acebo C, Carskadon MA. Sleep, circadian rhythms, and delayed phase in adolescence. Sleep Med. 2007;8(6):602–12.

    Article  PubMed  Google Scholar 

  125. Katzenberg D, et al. A CLOCK polymorphism associated with human diurnal preference. Sleep. 1998;21(6):569–76.

    Article  PubMed  CAS  Google Scholar 

  126. Xu X, et al. Association study between a polymorphism at the 3′-untranslated region of CLOCK gene and attention deficit hyperactivity disorder. Behav Brain Funct. 2010;6:48.

    Article  PubMed  PubMed Central  Google Scholar 

  127. Charrier A, et al. Clock genes and altered sleep-wake rhythms: their role in the development of psychiatric disorders. Int J Mol Sci. 2017;18(5).

    Google Scholar 

  128. Korman M, et al. ADHD 24/7: circadian clock genes, chronotherapy and sleep/wake cycle insufficiencies in ADHD. World J Biol Psychiatry. 2018;1–16.

    Google Scholar 

  129. Bumb JM, et al. Associations of pineal volume, chronotype and symptom severity in adults with attention deficit hyperactivity disorder and healthy controls. Eur Neuropsychopharmacol. 2016;26(7):1119–26.

    Article  PubMed  CAS  Google Scholar 

  130. Czeisler CA, et al. Chronotherapy: resetting the circadian clocks of patients with delayed sleep phase insomnia. Sleep. 1981;4(1):1–21.

    Article  PubMed  CAS  Google Scholar 

  131. Dahl RE, Pelham WE, Wierson M. The role of sleep disturbances in attention deficit disorder symptoms: a case study. J Pediatr Psychol. 1991;16(2):229–39.

    Article  PubMed  CAS  Google Scholar 

  132. Burkhalter H, et al. The effect of bright light therapy on sleep and circadian rhythms in renal transplant recipients: a pilot randomized, multicentre wait-list controlled trial. Transpl Int. 2015;28(1):59–70.

    Article  PubMed  Google Scholar 

  133. Fargason RE, et al. Correcting delayed circadian phase with bright light therapy predicts improvement in ADHD symptoms: a pilot study. J Psychiatr Res. 2017;91:105–10.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Rybak YE, et al. An open trial of light therapy in adult attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2006;67(10):1527–35.

    Article  PubMed  Google Scholar 

  135. Gruber R, Grizenko N, Joober R. Delayed sleep phase syndrome, ADHD, and bright light therapy. J Clin Psychiatry. 2007;68(2):337–8.

    Article  PubMed  Google Scholar 

  136. Revell VL, et al. Advancing human circadian rhythms with afternoon melatonin and morning intermittent bright light. J Clin Endocrinol Metab. 2006;91(1):54–9.

    Article  PubMed  CAS  Google Scholar 

  137. Cajochen C, Krauchi K, Wirz-Justice A. Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol. 2003;15(4):432–7.

    Article  PubMed  CAS  Google Scholar 

  138. **e Z, et al. A review of sleep disorders and melatonin. Neurol Res. 2017;39(6):559–65.

    Article  PubMed  CAS  Google Scholar 

  139. Sletten TL, et al. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: a double-blind, randomised clinical trial. PLoS Med. 2018;15(6):e1002587.

    Article  PubMed  PubMed Central  Google Scholar 

  140. van Geijlswijk IM, Korzilius HP, Smits MG. The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep. 2010;33(12):1605–14.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Szeinberg A, Borodkin K, Dagan Y. Melatonin treatment in adolescents with delayed sleep phase syndrome. Clin Pediatr (Phila). 2006;45(9):809–18.

    Article  Google Scholar 

  142. Anand S, et al. Safety, tolerability and efficacy of drugs for treating behavioural insomnia in children with attention-deficit/hyperactivity disorder: a systematic review with methodological quality assessment. Paediatr Drugs. 2017;19(3):235–50.

    Article  PubMed  Google Scholar 

  143. Tjon Pian Gi CV, et al. Melatonin for treatment of slee** disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study. Eur J Pediatr. 2003;162(7–8):554–5.

    Article  PubMed  Google Scholar 

  144. Barrett JR, Tracy DK, Giaroli G. To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2013;23(10):640–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  145. Bendz LM, Scates AC. Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder. Ann Pharmacother. 2010;44(1):185–91.

    Article  PubMed  CAS  Google Scholar 

  146. Touitou Y, Reinberg A, Touitou D. Association between light at night, melatonin secretion, sleep deprivation, and the internal clock: health impacts and mechanisms of circadian disruption. Life Sci. 2017;173:94–106.

    Article  PubMed  CAS  Google Scholar 

  147. Ivanenko A, editor. Sleep and psychiatric disorders in children and adolescents. New York: Informa Healthcare; 2008.

    Google Scholar 

  148. Hoebert M, et al. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res. 2009;47(1):1–7.

    Article  PubMed  CAS  Google Scholar 

  149. Wolraich M, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–22.

    Article  PubMed  Google Scholar 

  150. Morash-Conway J, Gendron M, Corkum P. The role of sleep quality and quantity in moderating the effectiveness of medication in the treatment of children with ADHD. Atten Defic Hyperact Disord. 2017;9(1):31–8.

    Article  PubMed  Google Scholar 

  151. Kidwell KM, et al. Stimulant medications and sleep for youth with ADHD: a meta-analysis. Pediatrics. 2015;136(6):1144–53.

    Article  PubMed  Google Scholar 

  152. Lee SH, et al. Effect of methylphenidate on sleep parameters in children with ADHD. Psychiatry Investig. 2012;9(4):384–90.

    Article  PubMed  PubMed Central  Google Scholar 

  153. Galland BC, Tripp EG, Taylor BJ. The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case-control study. J Sleep Res. 2010;19(2):366–73.

    Article  PubMed  Google Scholar 

  154. Corkum P, et al. Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder. J Pediatr Psychol. 2008;33(4):368–79.

    Article  PubMed  Google Scholar 

  155. Schwartz G, et al. Actigraphic monitoring during sleep of children with ADHD on methylphenidate and placebo. J Am Acad Child Adolesc Psychiatry. 2004;43(10):1276–82.

    Article  PubMed  Google Scholar 

  156. De Crescenzo F, et al. The use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysis. Atten Defic Hyperact Disord. 2014;6(1):49–58.

    Article  PubMed  Google Scholar 

  157. Ahmann PA, et al. Placebo-controlled evaluation of Ritalin side effects. Pediatrics. 1993;91(6):1101–6.

    Article  PubMed  CAS  Google Scholar 

  158. Stein MA, Weiss M, Hlavaty L. ADHD treatments, sleep, and sleep problems: complex associations. Neurotherapeutics. 2012;9(3):509–17.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  159. Sangal RB, et al. Effects of atomoxetine and methylphenidate on sleep in children with ADHD. Sleep. 2006;29(12):1573–85.

    Article  PubMed  Google Scholar 

  160. Stein MA, et al. Methylphenidate dosing: twice daily versus three times daily. Pediatrics. 1996;98(4 Pt 1):748–56.

    Article  PubMed  CAS  Google Scholar 

  161. Becker SP, Froehlich TE, Epstein JN. Effects of methylphenidate on sleep functioning in children with attention-deficit/hyperactivity disorder. J Dev Behav Pediatr. 2016;37(5):395–404.

    Article  PubMed  PubMed Central  Google Scholar 

  162. Pearson DA, et al. Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42(2):209–16.

    Article  PubMed  Google Scholar 

  163. Owens J, et al. Effect of aptensio XR (methylphenidate HCl extended-release) capsules on sleep in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2016;26(10):873–81.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  164. Faraone SV, et al. Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD. J Atten Disord. 2009;12(4):308–15.

    Article  PubMed  Google Scholar 

  165. Huang YS, Tsai MH, Guilleminault C. Pharmacological treatment of ADHD and the short and long term effects on sleep. Curr Pharm Des. 2011;17(15):1450–8.

    Article  PubMed  CAS  Google Scholar 

  166. O’Brien LM, et al. The effect of stimulants on sleep characteristics in children with attention deficit/hyperactivity disorder. Sleep Med. 2003;4(4):309–16.

    Article  PubMed  Google Scholar 

  167. Kim HW, et al. The effect of OROS methylphenidate on the sleep of children with attention-deficit/hyperactivity disorder. Int Clin Psychopharmacol. 2010;25(2):107–15.

    Article  PubMed  Google Scholar 

  168. Vigliano P, et al. Sleep in children with attention-deficit/hyperactivity disorder (ADHD) before and after 6-month treatment with methylphenidate: a pilot study. Eur J Pediatr. 2016;175(5):695–704.

    Article  PubMed  CAS  Google Scholar 

  169. Michelson D, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry. 2003;53(2):112–20.

    Article  PubMed  CAS  Google Scholar 

  170. Michelson D, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics. 2001;108(5):E83.

    Article  PubMed  CAS  Google Scholar 

  171. Bymaster FP, et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology. 2002;27(5):699–711.

    Article  PubMed  CAS  Google Scholar 

  172. Kratochvil CJ, et al. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry. 2002;41(7):776–84.

    Article  PubMed  Google Scholar 

  173. Spencer T, et al. Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002;63(12):1140–7.

    Article  PubMed  CAS  Google Scholar 

  174. Garnock-Jones KP, Keating GM. Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatr Drugs. 2009;11(3):203–26.

    Article  PubMed  Google Scholar 

  175. Yildiz O, et al. Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions. Child Psychiatry Hum Dev. 2011;42(3):257–69.

    Article  PubMed  Google Scholar 

  176. Adler LA, et al. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety. 2009;26(3):212–21.

    Article  PubMed  CAS  Google Scholar 

  177. Adler LA, et al. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol. 2009;29(1):44–50.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Integrative Program in Neuroscience, McGill University, Montréal, QC, Canada

    Jenny Dimakos

  2. Attention, Behavior and Sleep Lab, Douglas Mental Health University Institute, Montréal, QC, Canada

    Jenny Dimakos, Lisa-Marie Giorgio & Reut Gruber

  3. Department of Educational and Counselling Psychology, McGill University, Montréal, QC, Canada

    Lisa-Marie Giorgio

  4. Department of Psychiatry, Faculty of Medicine, McGill University, Montréal, QC, Canada

    Reut Gruber

Authors
  1. Jenny Dimakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lisa-Marie Giorgio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Reut Gruber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reut Gruber .

Editor information

Editors and Affiliations

  1. Department of Psychiatry and Division of Sleep Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India

    Ravi Gupta

  2. Department of Psychiatry, Johns Hopkins Medical School, Baltimore, MD, USA

    David N. Neubauer

  3. Somnogen Canada Inc., Toronto, ON, Canada

    S. R. Pandi-Perumal

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dimakos, J., Giorgio, LM., Gruber, R. (2022). Sleep and Attention-Deficit/Hyperactivity Disorder. In: Gupta, R., Neubauer, D.N., Pandi-Perumal, S.R. (eds) Sleep and Neuropsychiatric Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-16-0123-1_25

Download citation

Publish with us

Policies and ethics

Search

Navigation